Williams Insulation is a part of Masco Contractor Services, which is a group of subsidiaries owned by Masco Corporation. Masco Corporation manufactures, sells and installs home improvement and building products.
Williams Insulation offers various forms of insulation installations such as fiberglass batt, blown fiberglass, spray foam and cellulose. It also offers fireplaces and gutters. The company already serves both homebuilders and homeowners in Southeast Texas and Southwest Louisiana. Expansion in the Lake Charles area will further broaden the company�� client base.
Recently, another Masco Contractor Services unit , Red Lion Insulation, announced its plans to expand into Farmingdale, N.J. Red Lion offers various forms of insulation installations such as fiberglass batt, blown fiberglass, spray foam and cellulose.
Masco Corporation will report its second quarter 2013 earnings results on Jul 30, 2013. The Zacks Consensus Estimate for the quarter stands at 19 cents per share. The Zacks Consensus Estimate for 2013 is 69 cents while that for fiscal 2014 is $1.02 per share.
5 Best High Tech Stocks To Invest In 2015: FibroGen Inc (FGEN)
FibroGen, Inc. (FibroGen) is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat unmet medical needs. The Company focuses in the areas of fibrosis and hypoxia-inducible factor (HIF) biology. FibroGen�� products include Roxadustat (FG-4592), which is an oral small molecule inhibitor of HIF prolyl hydroxylases (HIF-PHs), in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and FG-3019, which is a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer and liver fibrosis. The Company�� subsidiaries include FibroGen Europe Oy (FibroGen Europe) and FibroGen China Anemia Holdings, Ltd. (FibroGen China).
Roxadustat is the HIF-PH inhibitor in Phase III clinical development, which acts by stimulating the body�� natural pathway of erythropoiesis, or red blood cell production. Roxadustat represents a new paradigm for the treatment of anemia in CKD patients and offers injectable erythropoiesis stimulating agents (ESAs). 1,449 subjects have participated in 26 completed Phase I and II clinical studies for roxadustat in North America, Europe and Asia. The Company, along with its collaboration partners, Astellas Pharma Inc., (Astellas) and AstraZeneca AB,(AstraZeneca), has designed a global Phase III program to support regulatory approval of roxadustat in both NDD-CKD and DD-CKD patients in multiple geographies.
FG-3019 is the Company�� fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), a critical common element in the progression of fibrosis and associated diseases. In Phase II IPF clinical studies, FG-3019 demonstrated the stabilization of disease and, in human studies, reversal of lung fibrosis in some patients. In an open-label Phase II pancreatic cancer study of FG-3019 plus gemcitabine and erlotinib, FG-3019 demonstrated a dose-depen! dent improvement in one year survival rate. In 10 Phase I and Phase II clinical studies of FG-3019 to date involving over 340 subjects, FG-3019 has been tolerated across a range of doses studied, and there have been no dose-limiting toxicities observed as of November 13, 2014.
The Company competes with Threshold Pharmaceuticals, Inc., Gilead Sciences, Inc., Halozyme Therapeutics, Inc., Gilead Sciences, Inc., Celgene Corporation, Janssen Biotech, Inc., Johnson & Johnson, Inc., Sanofi, Novartis and Biogen Idec.
Advisors' Opinion:- [By John Udovich]
Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).
10 Best Building Product Stocks To Watch For 2014: Sedex Mining Corp (SDN)
Sedex Mining Corp. is a resource exploration-stage company. The Company is engaged in the acquisition and exploration of exploration and evaluation assets. The Company�� Elephant Lake property is approximately 100 kilometers south of Timmins Ontario which has produced over 67 million ounces of gold. The Nickel North property lies approximately 22 kilometers northwest of the Kidd Creek Mine. The Kidd Creek Mine has produced over 115,000,000 tons of ore averaging 2.2% copper (Cu), 7.25% zinc (Zn), 0.28% lead (Pb) and 147.43 g/t silver (Ag)). Nordica property lies 55 kilometers southeast of Timmins, a prolific gold producing camp with. The property also lies approximately 24 kilometers southeast of Langmuir Township, a well known nickel belt with four known nickel deposits and GCR's recent W4 nickel discovery. Advisors' Opinion:- [By ICRAOnline]
Avago had inherited the Axxia Networking business after acquiring semiconductor player LSI Corp. last December. LSI�� Axxia portfolio included communication processors or chips that are used in switches and routers for high-performance networking, particularly software-defined-networking (SDN). Axxia chips help data center and enterprise network in transferring information efficiently.
10 Best Building Product Stocks To Watch For 2014: Komatsu Ltd (KMTUY)
Komatsu Ltd. (Komatsu), incorporated in May 13, 1921, is a global company engaged in the manufacturing, development, marketing and sale of a range of industrial-use products and services. The manufacturing operations of Komatsu are conducted primarily at plants located in Japan, the United States, Brazil, the United Kingdom, Germany, Sweden, Italy, Indonesia, China, Thailand and India. Komatsu�� products are primarily sold under the Komatsu brand name and almost all of its sales and service activities are conducted through its sales subsidiaries and independent distributors who primarily sell products to retail dealers in their respective geographic area. Komatsu operates and competes in the six principal markets, such as Japan, the United States, Europe and Commonwealth of Independent States (CIS), China, Asia (excluding Japan and China) and Oceania and the Middle East and Africa. In May, 2009, Komatsu acquired the additional interest in Komatsu Australia Corporate Finance Pty. Ltd.
Construction, Mining and Utility Equipment
The Company offers various types of construction, mining and utility equipment, ranging from super-large machines capable of mining applications to general construction equipment and mini construction equipment for urban use. Komatsu�� range of products in this operating segment also includes a variety of attachments to be used with its products. Komatsu�� principal products include excavating equipment, loading equipment, grading and roadbed preparation equipment, hauling equipment, forestry equipment, tunneling machines, recycling equipment, industrial vehicles, other equipment, engines and components, casting products and logistics.
Industrial Machinery and Others
The Company�� Industrial Machinery and Others segment products are used by a range of businesses and include industrial machinery, such as forging and sheet metal machinery and other services. Komatsu�� principal products include metal forging and stampi! ng presses, sheet metal machines, machine tools, defense systems, temperature-control equipment and others.
The Company competes with Caterpillar Inc., Hitachi Construction Machinery Co., Ltd., Volvo Construction Equipment NV, CNH Global N.V., Hyundai Heavy Industries Co., Ltd., Doosan Infracore Co., Ltd. and Toyota Motor Corporation.
Advisors' Opinion:- [By Dan Carroll]
Chinese manufacturing and materials stocks may not be the only picks in trouble, however. Leading international manufacturers could see demand in the world's second-largest economy, cutting into lofty growth expectations that relied upon China's surge to make up for weakness elsewhere around the globe. Japanese industrial power Komatsu (NASDAQOTH: KMTUY ) , the second-largest industrial machinery manufacturer in the world, is betting on�growing Chinese demand this fiscal year, in combination with the weak yen, to fuel growth.
- [By Dan Carroll]
An up-and-down yen spurs an up-and-down market
Abe brought about stimulus in response to one of Japan's worst economic problems of the last half-century: more than two decades of a stagnant economy and deflation. Weakening the yen against other leading currencies would be a boon for leading Japanese exporters looking for an edge against overseas competition. Manufacturers such as Komatsu (NASDAQOTH: KMTUY ) have applauded the moves as they look to use a weak yen to grow profits. Komatsu alone projected 46% full-year profit growth this year thanks to the weak yen.
10 Best Building Product Stocks To Watch For 2014: Rockwell Automation Inc.(ROK)
Rockwell Automation, Inc. provides industrial automation power, control, and information solutions. It operates in two segments, Architecture and Software, and Control Products and Solutions. The Architecture and Software segment offers control platforms that perform multiple control disciplines and monitoring of applications, including discrete, batch and continuous process, drives control, motion control, and machine safety control; and products comprising controllers, electronic operator interface devices, electronic input/output devices, communication and networking products, and industrial computers. This segment also offers software products, such as configuration and visualization software used to operate and supervise control platforms, advanced process control software, and manufacturing execution software to enhance manufacturing productivity and meet regulatory requirements; and rotary and linear motion control products, and sensors and machine safety components . The Control Products and Solutions segment provides low and medium voltage electro-mechanical and electronic motor starters, motor and circuit protection devices, AC/DC variable frequency drives, push buttons, signaling devices, termination and protection devices, relays and timers, and condition sensors; and packaged solutions, such as configured drives and motor control centers to automation and information solutions, as well as life-cycle support services. The company sells its products, solutions, and services primarily under the Rockwell Automation, Allen-Bradley, A-B, and Rockwell Software brand names to the food and beverage, transportation, oil and gas, metals, mining, home and personal care, pulp and paper, and life sciences markets through independent distributors and direct sales force in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Rockwell Automation, Inc. was founded in 1928 and is headquartered in Milwaukee , Wisconsin.
Advisors' Opinion:- [By Rich Duprey]
Industrial automation specialist�Rockwell Automation� (NYSE: ROK ) �announced yesterday�its third-quarter dividend of $0.52 per share, the same rate it paid last quarter after raising the payout almost 11% from $0.47 per share.
- [By Rick Munarriz]
Rockwell Automation (NYSE: ROK ) isn't being an automaton with its disbursements. The leading player in industrial automation and information is jacking up its quarterly payouts 11% to $0.52 a share. This may not seem like much, but string enough of these increases along and you really move the needle. Rockwell's rate has soared 80% over the past four years.
- [By Ben Levisohn]
That negative sentiment “flashed as a positive indicator,” Inch and Lau say, and some stocks appear to be “‘locked and loaded’ to meaningfully exceed forecast estimates.” Those include Rockwell Automation (ROK), Eaton (ETN) and Emerson Electric (EMR).
- [By Ben Levisohn]
Barclays’ Scott Davis and team believe it might be, and for evidence they look at�3M (MMM), Emerson Electric (EMR), Rockwell Automation (ROK), and MSC Industrial Direct (MSM). They write:
10 Best Building Product Stocks To Watch For 2014: BIND Therapeutics Inc (BIND)
BIND Therapeutics, Inc., incorporated on May 19, 2006, is a clinical-stage nanomedicine platform company developing Accurins, its targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Its drug candidate, BIND-014, is in Phase II clinical trials for non-small cell lung cancer, or NSCLC, and metastatic castrate-resistant prostate cancer (mCRPC).
Accurins represent the evolution of targeted therapies and nanomedicine. Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload. The four components include Targeting ligands, Stealth and protective layer, Controlled-release polymer matrix and Therapeutic payload. The Company focuses to use its medicinal nanoengineering platform to develop Accurins in several therapeutic areas, with an initial focus on the treatment of various types of cancer. In addition, the Company entered into collaboration agreements with several biopharmaceutical companies to develop and commercialize Accurins that are based on its collaborators��therapeutic payloads. The Company�� programs include BIND-014, solid tumor accurin and hematologic cancer accurin.
Advisors' Opinion:- [By Anna Prior]
Bind Therapeutics sa(BIND)id a collaboration with Amgen Inc.(AMGN) has been ended after both companies agreed not to pursue an option to jointly develop a molecularly targeted cancer therapy. Bind Therapeutics shares fell 11% to $11.50 premarket.
10 Best Building Product Stocks To Watch For 2014: Carrefour SA (CRERF)
Carrefour SA is a France-based company that is primarily engaged in retail distribution sector. The Company operates a network of hypermarkets, supermarkets, hard discount stores, convenience stores and cash-and-carry outlets and offers e-commerce services. The Company's hypermarkets named Carrefour offer a range of food and non-food products. Carrefour SA�� hypermarkets, supermarkets and convenience stores are operating under the Carrefour city, Carrefour contact, Carrefour express, 8aHuit, Shopi, Marche Plus, Proxi banners and cash & carry stores are operating under the Promocash banner, which primarily offer food, clothing and household goods, among others. The Company operates in mainland France and French overseas territories, as well as in Europe, Asia, Latin America, North Africa and the Middle East through a network of consolidated and franchised stores, and stores that Carrefour SA runs with partner companies. In January 2014, it acquired 129 convenience stores. Advisors' Opinion:- [By Sophia Yan]
Carrefour (CRERF) has also shuttered many stores, and is reported to be exploring a sale of its China and Taiwan businesses.
Hypermarkets -- big box stores that combine supermarkets and department stores -- first opened up in China's largest cities over a decade ago. And it's no wonder companies such as Wal-Mart have been keen to get a slice of the market.
10 Best Building Product Stocks To Watch For 2014: RCS Capital Corp (RCAP)
RCS Capital Corporation, incorporated on December 27, 2012, is a holding company. The Company is engaged in the business of wholesale broker-dealer, investment banking and capital markets business, a transaction management services provider and a transfer agent. The Company is externally managed and advised by RCS Capital Management, LLC. The Company owns interest in the subsidiaries of RCAP Holdings, LLC, which it refers to as the Company�� operating subsidiaries. These subsidiaries are Realty Capital Securities, LLC (Realty Capital Securities), American National Stock Transfer, LLC, and RCS Advisory Services, LLC. Realty Capital Securities, LLC is engaged in wholesale broker-dealer business. RCS Advisory Services, LLC is engaged in transaction management services business. American National Stock Transfer, LLC is engaged in transfer agent business. In September 2014, the Company acquired Strategic Capital Advisory Services and SC Distributors, LLC.
The Company�� wholesale broker-dealer is a wholesale distribution of publicly registered non-traded real estate and business development company securities. Operating under the name RCS Capital, the Company�� investment banking and capital markets business provides strategic advisory and capital markets services with a focus on the direct investment program industry, including sourcing, structuring and maintaining a range of debt finance and derivative arrangements on behalf of its clients. Operating under the name RCS Capital, the Company�� transaction management services provides a range of services to direct investment programs, publicly traded real estate investment trust (REITs) and their sponsors, including offering registration and blue sky filings, regulatory advice with respect to the Securities and Exchange Commission (SEC), and Financial Industry Regulatory Authority, Inc (FINRA) registration maintenance, transaction management, marketing support, due diligence advice and related meetings, events, training and education, co! nference management and strategic advice in connection with liquidity events and other strategic transactions. American National Stock Transfer, LLC is registered as a transfer agent with the SEC and will act as a registrar, provide record-keeping services and execute the transfer, issuance and cancellation of shares or other securities in connection with offerings conducted by issuers sponsored directly or indirectly by American Realty Capital.
Advisors' Opinion:- [By Jayson Derrick]
RCS Capital (NYSE: RCAP) said that it will no longer pursue its $700-million acquisition of Cole Capital Advisors from American Realty Capital (NASDAQ: ARCP). Shares of RCS Capital hit new 52-week lows of $13.55 before closing the day at $13.69, down 16.58 percent. Shares of American Realty Capital also hit new 52-week lows of $7.38 before closing the day at $7.85, down 11.50 percent.
No comments:
Post a Comment